2YIX | Transferase | date | May 17, 2011 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Triazolopyridine Inhibitors Of P38 | ||||||||||||||
authors | D.S.Millan, M.Anderson, M.E.Bunnage, J.L.Burrows, K.J.Butcher, P. T.J.Evans, D.A.Fairman, S.Han, S.J.Hughes, S.L.Irving, I.C.Kilty A.Lemaitre, R.A.Lewthawaite, A.Mahke, E.Marr, J.P.Mathias, J.Phi C.Phillips, R.T.Smith, M.H.Stefaniak, M.Yeadon | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Mitogen-Activated Protein Kinase 14 Chain: A Fragment: Residues 4-354 Synonym: P38 Kinase, Map Kinase 14, Mapk 14, Cytokine Suppr Anti-Inflammatory Drug-Binding Protein, Csaid-Binding Prot Csbp, Map Kinase Mxi2, Max-Interacting Protein 2, Mitogen-Activated Protein Kinase P38 Alpha, Map Kinase P38 Sapk2a; Ec: 2.7.11.24 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.30 Å | ||||||||||||
ligand | YIX BindingDB | enzyme | Transferase E.C.2.7.11.24 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease., Millan DS, Bunnage ME, Burrows JL, Butcher KJ, Dodd PG, Evans TJ, Fairman DA, Hughes SJ, Kilty IC, Lemaitre A, Lewthwaite RA, Mahnke A, Mathias JP, Philip J, Smith RT, Stefaniak MH, Yeadon M, Phillips C, J Med Chem. 2011 Nov 24;54(22):7797-814. Epub 2011 Oct 28. PMID:21888439 |
Data retrieval |
View 2YIX in 3D |
Visual 3D analysis of 2YIX |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2YIX |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |